Korro Bio (KRRO) Invested Capital (2021 - 2023)

Korro Bio's Invested Capital history runs 3 years deep, the most recent figure standing at $11.7 million for Q1 2023.

• Quarterly Invested Capital rose 250.05% year-over-year to $11.7 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $11.7 million (down 57.57% YoY) and the FY2022 annual result came in at $10.0 million, up 1100.48% from the prior year.
• Invested Capital was $11.7 million for Q1 2023 at Korro Bio, up from $10.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $11.7 million in Q1 2023 and bottomed at $833000.0 in Q4 2021.
• A 3-year average of $6.7 million and a median of $7.1 million in 2022 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital jumped 1100.48% — and 2023, when it surged 250.05%.
• Korro Bio's Invested Capital stood at $833000.0 in 2021, then soared by 1100.48% to $10.0 million in 2022, then grew by 16.67% to $11.7 million in 2023.
• Business Quant data shows KRRO's Invested Capital at $11.7 million in Q1 2023, $10.0 million in Q4 2022, and $8.3 million in Q3 2022.